Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Intersect Ent Inc (XENT)

Intersect Ent Inc (XENT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 954,907
  • Shares Outstanding, K 33,814
  • Annual Sales, $ 106,750 K
  • Annual Income, $ -159,640 K
  • 60-Month Beta 1.45
  • Price/Sales 8.95
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade XENT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.67
  • Most Recent Earnings -0.70 on 03/08/22
  • Next Earnings Date 05/16/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 7.66%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/22
See More
  • Average Estimate -0.34
  • Number of Estimates 1
  • High Estimate -0.34
  • Low Estimate -0.34
  • Prior Year -0.51
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.30 +3.44%
on 05/02/22
28.25 -0.04%
on 05/12/22
+0.31 (+1.11%)
since 04/12/22
3-Month
27.00 +4.59%
on 02/24/22
28.25 -0.04%
on 05/12/22
+0.91 (+3.33%)
since 02/11/22
52-Week
15.92 +77.39%
on 06/23/21
28.25 -0.04%
on 05/12/22
+10.62 (+60.27%)
since 05/12/21

Most Recent Stories

More News
Sientra (SIEN) Reports Q1 Loss, Tops Revenue Estimates

Sientra (SIEN) delivered earnings and revenue surprises of -11.54% and 5.67%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

SIEN : 0.8400 (+0.27%)
XENT : 28.24 (unch)
Chart of the Day: Intersect Ent Inc. Surges to a 2-Year High

The Barchart Chart of the Day belongs to Intersect Ent Inc. (XENT) . I found the stock by using Barchart.com to find the "Barchart New Highs" page, and then I clicked on pull-down to select stocks with...

XENT : 28.24 (unch)
Intersect ENT (XENT) Q1 Earnings & Revenues Miss Estimates

Intersect ENT (XENT) records lower-than-expected revenues for the first quarter, with mounting operating costs impacting the bottom line.

UNH : 517.40 (+0.73%)
ALKS : 30.53 (+2.48%)
MDT : 91.38 (+1.82%)
XENT : 28.24 (unch)
DexCom (DXCM) Misses Q1 Earnings Estimates

DexCom (DXCM) delivered earnings and revenue surprises of -36% and 1.47%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

DXCM : 77.63 (+4.16%)
XENT : 28.24 (unch)
SeaSpine Holdings (SPNE) Reports Q4 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of -44.44% and 1.33%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

SPNE : 5.79 (+2.48%)
XENT : 28.24 (unch)
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates

OrthoPediatrics (KIDS) delivered earnings and revenue surprises of 17.24% and 0.13%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

KIDS : 42.90 (-0.58%)
XENT : 28.24 (unch)
Teleflex (TFX) Q4 Earnings and Revenues Surpass Estimates

Teleflex (TFX) delivered earnings and revenue surprises of 1.98% and 1.87%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

TFX : 255.09 (+3.76%)
XENT : 28.24 (unch)
TransMedics (TMDX) Reports Q4 Loss, Tops Revenue Estimates

TransMedics (TMDX) delivered earnings and revenue surprises of -6.98% and 26.21%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

TMDX : 31.97 (+1.65%)
XENT : 28.24 (unch)
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization

Intersect ENT ® , Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced positive results of an observational,...

XENT : 28.24 (unch)
Orthofix Announces Appointment of Thomas A. West to Board of Directors

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that Thomas A. West has been named to the Company’s Board of Directors and appointed...

OFIX : 24.29 (+3.19%)
XENT : 28.24 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Intersect ENT, Inc. is a commercial drug-device company. The Company's initial products, PROPEL and PROPEL mini, are drug-eluting implants for use in patients with chronic sinusitis. It offers products and therapies for ear, nose, and throat surgeons to improve treatment for their patients with chronic...

See More

Key Turning Points

3rd Resistance Point 28.27
2nd Resistance Point 28.26
1st Resistance Point 28.25
Last Price 28.24
1st Support Level 28.23
2nd Support Level 28.22
3rd Support Level 28.21

See More

52-Week High 28.25
Last Price 28.24
Fibonacci 61.8% 23.54
Fibonacci 50% 22.08
Fibonacci 38.2% 20.63
52-Week Low 15.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar